PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 56: Articles 27501-28000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Plasma and urine levels produced by an oral dose of ampicillin 0.5 G administered to women taking oral contraceptives.
  2. Plasma bradykininogen levels before and after ovulation: studies in women and guinea pigs, with observations on oral contraceptives and menopause.
  3. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
  4. Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel.
  5. Plasma lipoprotein changes during oral contraception.
  6. Plasma renin activity, reactivity, concentration and substrate following hypertension during pregnancy: effect or oral contraceptive agents.
  7. Plasma Xa inhibitory activities and plasma concentrations of norgestrel and ethinyloestradiol in women on oral contraceptive steroids. (Letter)
  8. Plasmalipids, lipoproteins, and blood pressure in female adolescents using oral contraceptives.
  9. Political will and family planning: the implications of India's emergency experience.
  10. The politics of contraception.
  11. Polyurethane contraceptive vaginal sponge: product modification resulting from user experience.
  12. Popular distribution of contraceptive products, Mexico-1978. [La distribucion popular de productos anticonceptivos, Mexico-1978.]
  13. Population and family planning in Thailand.
  14. Population and family planning programs: supplementary tables to the ninth edition of the Fact Book.
  15. The population matter between family planning and development projects in Egypt: a summary.
  16. Population processes in rural Yemen: temporary emigration, breastfeeding, and contraception.
  17. Population, family planning and development: communication needs for the 1980s.
  18. Population/Family Planning/Environmental Education Workshop, Egypt.
  19. The Portuguese and family planning: two opinion research studies on levels of understanding and attitude. [Os Portugueses e o planeamento familiar: dois estudos de opiniao sobre niveis de conhecimento e atitude.]
  20. A position paper on the relation between oral contraceptives and blood coagulation.
  21. Possible hazards of oral contraceptive use.
  22. Post-abortion attitudes and patterns of birth control.
  23. Postpartum and postabortal contraception.
  24. Postpartum family planning program at Concepcion Palacios Maternity Hospital, Caracas, Venezuela.
  25. Postpartum IUD insertion safe, acceptable contraception.
  26. The potential for an androgen male contraceptive.
  27. Practice of midwifery: prescribing of contraceptives.
  28. Preclinical evaluation of new vaginal contraceptives.
  29. Prediction of family planning and family size from modernity value orientations of Indian women.
  30. Pregnancies with intra-uterine contraceptive device in situ. [Grossesses sur sterilet.]
  31. Pregnancy and contraception in adolescence.
  32. Pregnancy following oral contraception. [Grossesse apres contraception orale.]
  33. Pregnancy rate of a progestogen oral contraceptive.
  34. Pregnancy, oral contraceptives and multiple sclerosis.
  35. A preliminary assessment of the feasibility of a subsidized contraceptive marketing program for Guatemala.
  36. A preliminary assessment of the feasibility of a subsidized contraceptive marketing program for Morocco.
  37. A preliminary assessment of the feasibility of a subsidized contraceptive marketing program for Peru.
  38. A preliminary report on the Collatex Sponge: a new female barrier contraceptive.
  39. Preliminary results of a multi-clinic trial of a polyurethane-spermicide contraceptive sponge. Addendum.
  40. Preliminary results of a multiclinic trial of a polyurethane-spermicide contraceptive sponge.
  41. Premarital classes encourage family planning in Republic of China.
  42. Premarital contraceptives usage among male and female adolescents.
  43. Prescribing information: Copper T Model TCu 380 Ag brand of intrauterine copper contraceptive.
  44. Prescribing oral contraceptives.
  45. President's budget proposes no increase for family planning services in FY 1980.
  46. Prevalence and use of contraceptives in Colombia: determinants and implications. [Prevalencia del uso de anticonception en Colombia: determinantes e implicaciones.]
  47. Prevalence of pre-malignant lesions of the cervix uteri: comparative study between a female population using contraceptives. [Prevalencia de lesiones premalignas y malignas del cuello uterino: estudio comparativo entre poblacion femenina usando anticonceptivos.]
  48. The price of contraceptives in Europe.
  49. Primary health care with special reference to nutrition, MCH and family planning.
  50. Primary malignant liver tumors: association with oral contraceptives.
  51. Primary malignant tumor of the liver associated with the ingestion of oral contraceptives. [Tumeur maligne primitive du foie associee a la prise d'estro-progestatifs.]
  52. Probing discontinuance: why people stop using contraceptives.
  53. Problem of oral surgical interventions during pregnancy, menstruation and under the intake of hormonal contraceptives. [Zur Problematik stomatologisch-chirurgischer Eingriffe waehrend der Schwangerschaft, Menstruation und unter der Einnahme hormonaler Kontrazeptiva.]
  54. Problem-solving skills, locus of control, and the contraceptive effectiveness of young women.
  55. Problems in research utilization: evaluation research undertaken at the Korean Institute for Family Planning.
  56. Problems of contraception: light bleeding due to coil (loop) [Petits problemes de la contraception: petits saignements dus au sterilet.]
  57. Problems posed by birth control in cardiac and hypertension patients (author's transl) [Problemes poses par la regulation des naissances chez les cardiaques et les hypertendues.]
  58. Production strategies in developing family planning IEC materials.
  59. Profile of a minilaparotomy acceptor at an FPA (Family Planning Association of Sri Lanka Clinic)
  60. Profiles: Federal laws and policies relating to family planning, contraception, voluntary sterilization and abortion.
  61. Profiles: Laws and health, welfare and Medicaid agency policies on family planning, contraception, voluntary sterilization, abortion and services to minors, for each state and federal jurisdiction.
  62. Progressive rise in serum copper levels in women taking oral contraceptives: a potential hazard?
  63. Project Compassion--its process-oriented approach to family planning.
  64. Prolonged amenorrhea and oral contraceptives.
  65. A proposal on a study of the relationship between family planning, birth interval and child health in rural Korea.
  66. Prospective and retrospective studies of lipid-metabolism under oral contraception (author's transl) [Prospektive und retrospektive Untersuchungen von Parametern des Fettstoffwechsels bei Einnahme von Kontrazeptiva.]
  67. Prospective studies of the gonadotropin responses to graded injections of gonadotropin-releasing factor in women using a low-estrogen type oral contraceptive for three months.
  68. A prospective, randomized study of oral contraceptives: the effect of study design on reported rates of symptoms.
  69. Prospects and problems in the development of an intravaginal contraceptive device (IVCD) and method.
  70. Prostaglandin levels in menstrual fluid of nondysmenorrheic and of dysmenorrheic subjects with and without oral contraceptive or ibuprofen therapy.
  71. Prostaglandins and contraception (author's transl) [Prostaglandine e contraccezione.]
  72. The protective influence of progestogen only contraception against vaginal moniliasis.
  73. Provision of family planning experience: the Malaysian experience.
  74. Provision of family planning services in India.
  75. Psycho-social aspects of contraception.
  76. Psycho-social correlates of regular contraceptive use in young unmarried women. (Doctoral dissertation, Washington University, May 1978)
  77. Psychoanalytical approach of the current methods of contraception. [Approche psychanalitique de la contraception d'aujour'hui.]
  78. The psychodynamics of natural family planning and instructor training.
  79. Psychological affects of oral contraceptives.
  80. Psychological and situation-specific correlates of contraceptive behavior among university women.
  81. Psychological approach to intrauterine contraception.
  82. Psychological aspects in the choice of contraceptive methods.
  83. Psychological aspects of implementing natural family planning programs.
  84. Psychological aspects of oral contraception.
  85. Psychological factors in the prognosis of contraception. [Los factores psicologicos en la prognosis de la anticoncepcion.]
  86. The psychology of contraception.
  87. Psychosocial aspects of contraception.
  88. Psychosocial aspects of natural family planning.
  89. Psychosomatic side-effects of contraceptive methods.
  90. Public policies in conflict: land reform and family planning in Costa Rica.
  91. Pyridoxine held effective for controlling depression in women taking oral contraceptives.
  92. Qinghai achieves good results in planned parenthood.
  93. Quality assessment of barrier contraceptives.
  94. Quality assessment of barrier contraceptives.
  95. Quantitative enhancement of dinitrochlorobenzene responsivity in women receiving oral contraceptives.
  96. Radioimmunoassay for serum medroxyprogesterone acetate in Thai women receiving injectable DMPA contraceptive.
  97. A randomized double blind study of two oral contraceptives.
  98. A randomized double-blind trail of two low dose combined oral contraceptives.
  99. A randomized prospective study of the use-effectiveness of 2 methods of natural family planning: an interim report.
  100. A re-appraisal of contraception: benefits v. risks: report of an international symposium in Montreal.
  101. A reader in natural family planning: report on international conferences. 2nd ed.
  102. Reading profile on Islam and family planning: an index of materials, and how to obtain them.
  103. Real-time ultrasound in locating intrauterine contraceptive devices.
  104. The realization of family planning in Finland with particular reference to development in the 1970's.
  105. A reappraisal of the use and effectiveness of the diaphragm: an appropriate modern contraceptive.
  106. Reasonable surgical treatment for tumors of the liver associated with the use of oral contraceptives.
  107. Reasons for nonuse of contraception by sexually active women aged 15-19.
  108. Recent family planning programs and problems in India.
  109. Recommendations of the law and planned parenthood panel.
  110. Recommendations of the Swiss Family Planning Association regarding the indications for oral contraceptives. [Recommandations de la Societe Suisse pour le planning familial concernant la prescription des contraceptifs oraux.]
  111. Recruitment, training and evaluation of natural family planning teachers.
  112. Reduced hypertensive risks of low dose contraceptive steroids.
  113. Reflections on future contraception. [Reflexion d'un physiologiste sur la contraception future.]
  114. Regional estimates of contraceptive prevalence in February 1977.
  115. Regressive ischemia of the small intestine and contraceptives. [Ischemie regressive du grele et contraceptifs.]
  116. Regressive ulcerative colitis: probable participation of oral contraceptives in its etiology: report of a case. [Colite ulcereuse aigue regressive: role etiologique des contraceptifs oraux: a propos d'un cas.]
  117. The relation of law and rights in the work of family planning: Some remarks. [Das Verhaltnis von Gesetz und Recht in der Familien Familienplanungsarbeit. Einige Bemerkungen.]
  118. The relationship between contraceptive sex role stereotyping and attitudes toward male contraception among males.
  119. The relationship of unwanted teenage pregnancy to sex knowledge, attitudes toward birth control, acceptance of one's sexuality, parental acceptance, risk taking, and age.
  120. Relationship-centered family planning services: role of the family counselor.
  121. Relative potencies of oral contraceptives.
  122. The relevance of Calabar Rural Maternal and Child Health/Family Planning Project to national and state policies and programmes, Nigeria.
  123. The relevance of Mojokerto MCH-Family Planning Project to national policies and programs.
  124. Remarks on the principal complications and contraindications in the use of mechanical contraceptives. [Considerazioni sulle principali complicanze e controindicazioni dell'uso dei contraccettivi meccanici.]
  125. Renal artery thrombosis in a young woman taking oral contraceptives.
  126. Report of an assessment of the information, education and communication activities of Jamaica's National Family Planning Program.
  127. Report of the evaluation of UNFPA assistance to the National Family Planning Program of Mauritius.
  128. Report of the Regional Panel on Law and Planned Parenthood Meeting, Merlin Hotel, Kuala Lumpur, 7th April, 1979.
  129. Report on consultation: Jamaican Family Planning Association University of West Indies.
  130. Report on field research in Yucatan with recommendations for incorporating traditional birth attendants in family planning programs.
  131. Report on the study team (visiting 5 countries implementing the IPPF/JOICFP Integrated Program in Family Planning, Parasite Control and Nutrition.)
  132. A report on UNFPA/EWPI Technical Working Group Meeting on Integration of Family Planning with Rural Development, East-West Center, Honolulu, Hawaii 15-18 February 1978.
  133. Reported contraceptive practice in outreach program areas and its apparent effects on fertility.
  134. Reported incidence of abortion in world fertility surveys and contraceptive prevalence surveys.
  135. Reproductive endocrinology, infertility, and contraception.
  136. Reproductive outcomes in former oral contraceptive users.
  137. Republic of China (Taiwan): progress report of the Integrated Family Planning and Parasite Control Project.
  138. Republic of Korea: Contraceptive Prevalence Survey. Summary Report.
  139. Research in family planning.

     

  140. Research in vaginal contraception: an overview.
  141. Research on coagulation of human cervical mucus as a contraceptive process. [Recherches sur la coagulation de la secretion cervicale envisagee comme procede contraceptif.]
  142. Research on family planning and population problems: issues in utilization of research results for the future.
  143. Research on natural family planning: the WHO Task Force on Methods for the Determination of the Fertile Period.
  144. Research that has been undertaken abroad with regard to family-planning clinic drop-outs--a literature study.
  145. Results from the Bohol 1975 and 1978 Family Planning Acceptor Surveys.
  146. Retrieval of contraceptive device threads from within the uterine cavity.
  147. A retrospective clinical study of a vaginal contraceptive suppository.
  148. A review of changes in prevalence and patterns of contraceptive use in Bangladesh since 1976.
  149. A review of the birth control pill and its relationship to thrombophlebitis.
  150. Review of the Indonesian National Family Planning Program. Statement before the House Select Committee on Population, April 27, 1978.
  151. A review: adverse effects of oral contraceptives.
  152. Riboflavin nutritional status and absorption in oral contraceptive users and nonusers.
  153. Riboflavin nutriture of oral contraceptive users.
  154. Risk approach for maternal and child health care: a managerial strategy to improve the coverage and quality of maternal and child health/family planning services based on the measurement of individual and community risk.
  155. Risk of myocardial infarction in oral-contraceptive users.
  156. Risk of myocardial infarction in oral-contraceptive users.
  157. Risk of myocardial infarction in oral-contraceptive users. [Letter]
  158. Risk of sexual hormones administration during pregnancy. Pt 1. Pregnancy hormonal test and oral contraceptives (author's Transl) [O risco da administracao de hormonios sexuais na gravidez. Pt 1. Testes hormonais de gravidez e anticonceptivos orais.]
  159. Risk of vascular disease in women: smoking, oral contraceptives, noncontraceptive estrogens, and other factors.
  160. Risks and benefits of hormonal contraceptives. [Riscos e benficios dos contraceptivos hormonais.]
  161. Risks and benefits with various contraceptive methods. [Risker och foerdelar vid olika antikonceptionsmetoder.]
  162. Risks associated with the rhythm method of contraception. [Risques imputables a la methode contraceptive par abstinence periodique.]
  163. The risks of oral contraception.
  164. The role and challenge of voluntary sterilization in family planning programs.
  165. Role of combined oral contraceptives in the pathogenesis of disorders in the urodynamics of the upper urinary tract. [Rol Kombinivouannykh oral nykh kontvatseptiuov v patogeneze rasstroistv urodinamiki verkhnikh mochevykh pute i.]
  166. The role of communication in family planning.
  167. The role of industry in family planning.
  168. The role of male sterilization in family planning programmes.
  169. The role of midwives and nurses in family planning.
  170. Role of oral contraceptive agents in the pathogenesis of liver tumors.
  171. The role of the family planning counselor in French Switzerland. [La place dela conseillere de planning familial en Suisse romande.]
  172. The role of the private physician in surgical family planning: examples of private clinics contributing to family planning services.
  173. The role of the village head in the practice of family planning.
  174. The role of traditional birth attendants in family planning programs in Southeast Asia.
  175. The role of vasectomy in family planning in Thailand.
  176. The role of voluntary organisations in a communication strategy for family planning.
  177. The role of voluntary organizations in promoting family planning and population policy.
  178. The role of women in family planning development.
  179. The role of women in family planning development: (Discussion following paper)
  180. The role of women in population management with special reference to family planning.
  181. Romania raises birthrate by restricting abortion, birth control access.
  182. Routines for prescription of contraceptives (estrogen + gestagen) [Rutiner ved forskrivning av P-piller (ostrogen + gestagen)]
  183. Rural and urban family planning services in the.
  184. Rural development and family planning behavior in Bangladesh Villages.
  185. Rural Family Planning Motivational Programme.
  186. Safety and hazards of injectable hormonal contraceptives.
  187. Safety of the long-acting injectable contraceptive Depo-Provera: an assessment of recent findings from a 10-year study in monkeys.
  188. Sao Paulo Family Planning Center.
  189. Sao Paulo State contraceptive prevalence survey, PESMI/PUCC/78: Final Report, June, 1979.
  190. Sao Paulo state contraceptive prevalence survey: PESMI/PUCC/78 Final report, June 1979.
  191. Sao Paulo [Brazil] Contraceptive Prevalence Survey: demographic measurement.
  192. Sarikaya: toward community self-reliance in health and family planning.
  193. School children and contraception: knowledge, attitudes, and behavior. [Skoleungdom og praevention: Viden, holdning og adfaerd.]
  194. In search of the perfect contraceptive.
  195. Social marketing of contraceptives in Bangladesh: general review of program directions incorporating additional product expansion.
  196. Social welfare and family planning: concepts, strategies and methods. Report of a United Nations project, 1971-1978.
  197. Social Welfare, health and family planning in India.
  198. Social workers and family planning.
  199. Social-psychological study of family planning. [Estudio social-psicologico de la planificacion familiar.]
  200. A social-science perspective of research issues for natural family planning.
  201. Socialization factors in contraceptive attitudes: roles of affective responses, parental attitudes, and sexual experience.
  202. Socio-cultural factors that influence the individuals decision towards acceptance or non acceptance of surgical contraception.
  203. Socio-demographic and psychological aspects of contraceptive use. [Les aspects socio-demographiques de la contraception.]
  204. Socio-economic determinants of family planning acceptance in Madhya Pradesh.
  205. Socio-personal variables associated with attitudes of Tharus toward birth control.
  206. Socioeconomic variations in the perception of side-effects of contraceptives in Singapore: an exploratory analysis.
  207. Some aspects of knowledge and attitude towards family planning and sterilisation on the periurban area of Kampala, Uganda.
  208. Some aspects of practice of family planning as revealed in the NSS survey.
  209. Some estrogenic effects of two oral contraceptives consisting of norgestrel and two different doses of ethynylestradiol.
  210. Some factors related to men's stated willingness to use a male contraceptive pill.
  211. Some socio-cultural problems of the family planning communicator in Sri Lanka.
  212. Some techniques for evaluation of family planning programmes.
  213. Spatial population distribution and reduction of fertility and population growth through family planning services in Kenya.
  214. Special Report: Banjul Islam Conference endorses family planning.
  215. Spermatozoa repellent as a contraceptive.
  216. Spontaneous rupture of a liver adenoma after many years' ingestion of an oral contraceptive. [Spontanruptur eines Leberadenoms nach langjaehriger Einnahme eines Antikonzeptivums.]
  217. State of historical research on sexuality and contraception. [Etat des recherches historiques sur la sexualite et la contraception.]
  218. Statistico epidemiological study of changes in the vaginal flora of contraceptive pill users in Alexandria.
  219. Statistics on family planning. [Statistiques de planning familial.]
  220. Status and problems of contraception in the world and in Belgium in 1978. [Positions et problemes de la contraception dans le monde et en Belgique en 1978.]
  221. Status of funding and costs of reproductive science research and contraceptive development.
  222. The status of women and family planning.
  223. Sterility after contraception: regrets and responses. [La Sterilite post contraception: regrets et reponses.]
  224. Sterility and contraception; reciprocal incidence. [Steriliteet contraception: incidence reciproque.]
  225. Sterilization and contraceptive services in Catholic hospitals.
  226. Sterilization for contraceptive purposes in Catholic hospitals.
  227. Steroid contraception and human breast neoplasia.
  228. Steroidal contraceptives and congenital anomalies.
  229. Steroidal contraceptives and thromboembolic disease.
  230. Store displays increase contraceptive sales in El Salvador.
  231. Strategies for family planning motivation in Nepal.
  232. Strategies for family planning, health, and community development in rural Ecuador.
  233. A strategy for research utilization in family planning information, education and communication.
  234. A strategy for research utilization on population and family planning.
  235. Structural and histochemical characteristics of the endometrium in women using different types of intrauterine contraceptives. [Strukturnye i gistokhimicheskie osobennosti: endometriia zhenshchin pri primenenii vnutrimatochnykh kontratseptivov razlichnogo tipa.]
  236. Students win right to publish birth control story.
  237. Studies on liver function under the influence of oral contraceptives.
  238. Studies on low dose oral contraceptives: plasma hormone changes in relation to deliberate pill ("Microgynon 30") omission.
  239. Studies with cyproterone acetate for male contraception.
  240. Study of a contraceptive, antibacterial, anti-mycotic, and anti-VD pharmacologic association designed for topical use. [Studio su di una associazione farmacologica peruso topico ad azione anticoncezionale antibatteria, antimicotica e profilattica per le malattie veneree.]
  241. Study of a drug combination for topical use, with contraceptive, antibacterial and antimycotic action and venereal disease preventive action. 2. [Studiosu un'associazione farmacologica per uso topico ad azione anticoncezionale, antibatterica, antiicotica e profilattica per le malattie veneree. Nota 2.]
  242. Study of family planning program effectiveness: summary.
  243. A study of gamma-glutamyl-transpeptidase and of the ratio of IgA to transferrin in the pregnant woman (and when using oral contraception) and in the newborn (author's transl) [Etude de la gamma-glutamyl-transpeptidase et du rapport IgA sur transferrine chez la femme enceinte (et sous contraception orale) et le nouveau-ne.]
  244. A study of the conjugal interaction of the successful natural family planning practitioners of Iligan, Lanao del Norte.
  245. A study on characteristics of active family planning canvassers (author's transl)
  246. A study on negative information about contraceptive methods (author's transl)
  247. A study on new approach in maximization of family planning and health services in rural Korea: comparison between new village health worker and new village movement leader.
  248. A study on the effects of infant and child mortality on the mothers' fertility and contraceptive behaviors in rural Korea.
  249. Subcutaneous steroid hormone capsules. The future contraception? [Subkutane steroidhormonkapsler. Fremtidens kontraception?]
  250. Subdermal norethindrone pellets: a method for contraception?
  251. Suitability of the beagle dog as a test model for the tumorigenic potential of contraceptive steroids: a short review.
  252. Summary and analysis of Federal laws and policies relating to family planning, contraception, voluntary sterilization and abortion.
  253. Summary and analysis of state health, welfare and Medicaid agency policies on family planning, contraception, voluntary sterilization and abortion.
  254. Summary and analysis of state laws relating to contraception.
  255. Summary and analysis of state laws relating to contraceptive and abortion services to minors.
  256. A summary on the findings of assessment of the Bangladesh Contraceptive Social Marketing Project: methodology and basic data.
  257. Summary report of the Thai Integrated Family Planning and Parasite Control Programme, September 1976 - September 1978.
  258. Suppression of human spermatogenesis by depot androgen: potential for male contraception.
  259. Supraventricular cycle disorders due to oral contraceptives. [Supraventrikulaere Rhythmusstoerungen durch Ovulationshemmer?]
  260. Surgical contraception: far from being free. [La contraception chirurgicale: loin d'etre gratuite]]
  261. Surgical contraception: it's anything but free. [Editorial]
  262. Surveillance of women taking oral contraceptives by determination of antithrombin 3. [Surveillance des femmes prenant des contraceptifs oraux par la determination de l'antithrombin 3.]
  263. Survey of contraceptive use in Jamaica, 1979.
  264. Survey of family planning services provided to teen-agers by Public Health projects.
  265. Survey of primary liver tumors and oral contraceptive use.
  266. A survey of sterilization acceptors in a family planning program in rural Bangladesh.
  267. A survey on the method of contraception employed by women gynecologists and by wives of gynecologists in France. [Enquete sur la contraception des femmes gynecologues et des femmes de gynecologues en France.]
  268. Symposium on contraceptive technology.
  269. A symposium, Recent Advances in Contraception, Thredbo, Australia, February 24-26, 1979. (Abstract only)
  270. Systemic and local delivery of contraceptive steroids using biodegradable microcapsules.
  271. Taking family planning to the community -- Bombay, India.
  272. The Young Adult Clinic: eighteen months of a contraceptive and counseling service for young people, Oct., 1977 to March, 1979.
  273. Young Bangladeshi women want 3 children, bear about 6; contraceptives mostly unavailable.
  274. The Yozgat (Turkey) Maternal and Child Health and Family Planning Project: baseline information on socioeconomic and demographic conditions.
  275. Acceptability of family planning.
  276. Characteristics of women participating in the Family Planning Program of the Direcion General de Atencion Medica Materno Infantil y Planificacion Familiar de la SSA (author's transl) [Perfil de las usuarias del Programa de Planificacion Familiar de la Direccion General de Atencion Medica Materno Infantil y Planificacion Familiar de la SSA.]
  277. Effect of family planning programme on reduction in fertility in Haryana, 1965-75.
  278. Epidemiology and clinical significance of cervical erosion in women attending a family planning clinic.
  279. Family planning in the urban area of Merida, Yucatan. An account of restricting factors (author's transl) [Conocimientos sobre planificacion familiar en el area urbana de Merida, Yucatan. Causas que la limitan.]
  280. Screening for gonorrhoea in family planning acceptors in a developing community.
  281. Voluntary sterilization: world's leading contraceptive method./Sterilisation volontaire : principale methode mondiale de contraception./Esterilizacao voluntaria : o principal metodo mundial de contracepcao./Esterilizacion voluntaria : el metodo anticonceptivo de mayor aceptacion en el m.undo.
  282. Filling family planning gaps./Comment combler les lacunes du planning familial./Preenchendo lacunas do planejamento familiar./Como salvar la brecha en planificacion familiar.
  283. Community-based and commercial contraceptive distribution: an inventory and appraisal./Distribuicao comunitaria e comercial de contraceptivos: inventario e avaliacao./Distribution de contraceptifs : commerce ou base communautaire inventaire et evaluation./Distribucion de anticonceptivos por medios comerciales y basada en la comunidad : inventario y evaluacion.
  284. Contraception in the cardiac patient. [La contraception chez les cardiaques.]
  285. Contraception in the later part of the fertile period in Denmark.
  286. Contraception is compromise for pro-, antiabortionists.
  287. Contraception research: pills and Depo-Provera, contributions from England and the USA. [Kontrazaptionsforschung Pille und Depo Provera Beitrage aus England und den USA.]
  288. Contraception the day afterward. [La contraception du lendemain.]
  289. Contraception today.
  290. Contraception today: matching contraceptives to the user: what are the problems? (Statement, March 7, 1978)
  291. Contraception tomorrow. (Statement, March 8, 1978)
  292. Contraception using 3-monthly injections of Depo-Provera. [Contraception par l'injection trimestrelle de Depo-Provera.]
  293. Contraception with a norethisterone-releasing IUD. Plasma levels of norethisterone and its influence on the ovarian function.
  294. Contraception with long acting subdermal implants: measured and perceived effects in international clinical trials.
  295. Contraception with the intrauterine device Progestasert (author's transl) [Zur Kontrazeption mit dem Intrauterinpessar Progestasert.]
  296. Contraception, infallibility and the ordinary magisterium.
  297. The Contraception, Sterilization and Abortion Act, No. 112 of 16 December 1977, Section 7 through 9.
  298. The contraception-to-conception ratio: a tool for measuring success of family planning programs in reaching very young teenagers.
  299. Contraception.
  300. Contraception.
  301. Contraception. (Letter)
  302. Contraception. [Kontraception.]
  303. Contraception: an antipregnancy vaccine??
  304. Contraception: blessing or blight??
  305. Contraception: difficulties and objectives (Editorial) [La contraception: difficultes et objectifs.]
  306. Contraception: Why is it evil??
  307. Contraception? Facts on birth control.
  308. Contraceptive action of copper. (Letter)
  309. Contraceptive compliance in family medicine: a comparison of the family physician and the family planning clinics.
  310. Contraceptive continuation in high-risk women.
  311. Contraceptive counseling for the younger adolescent woman: a suggested solution to the problem.
  312. Contraceptive counseling.
  313. Contraceptive counselor's dilemma: safety or effectiveness??
  314. Contraceptive development studies for males: oral and parenteral steroid hormone administration.
  315. Contraceptive development, reproduction research may be curbed.
  316. Contraceptive development.
  317. Contraceptive distribution and family planning at community and household levels: institutional barriers and evaluation strategies.
  318. Contraceptive effectiveness.
  319. Contraceptive effectiveness: an attempt at a calculation. [Prevensjonsmetoders sikkerhet: et forsoek paa en beregning.]
  320. Contraceptive effects of 1-alpha-hydroxy-norethisterone. (Abstract only)
  321. The contraceptive effects of a new low-dose combination type oral contraceptive.
  322. Contraceptive efficacy among married women 15-44 years of age in the United States, 1970-73.
  323. Contraceptive efficacy determination by postcoital testing.
  324. Contraceptive evaluation.
  325. Contraceptive experience and associated personality variables.
  326. Contraceptive frequency in Paraguay.
  327. Contraceptive hormones and vascular disease.
  328. Contraceptive hormones, vascular risk and abnormal precipitation of serum gamma-globulins. [Hormones contraceptives, risque vasculaire et precipitabilite anormale des gamma-globulines seriques.]
  329. Contraceptive hormones: the problem of the induction of mammary gland nodules in beagle dogs given progestogens.
  330. Contraceptive interactions and nutritional implications of family planning.
  331. Contraceptive knowledge and use in the Petit Goave Region of Haiti. (A report prepared for the Division d'Hygiene Familiale, Departement de la Sante Publique et de la Population, Haiti)
  332. Contraceptive methods. [Methodes contraceptives.]
  333. Contraceptive methods: risks and benefits.
  334. Contraceptive patterns and premarital pregnancy among women aged 15-19 in 1976.
  335. Contraceptive practice after clinic discontinuation.
  336. Contraceptive practice among U.S. couples.
  337. Contraceptive practice in Thailand.
  338. Contraceptive practices in children and adolescents. [Empfangnisverhutung bei Kindern und Jugendlichen.]
  339. Contraceptive prevalence in Paraguay.
  340. Contraceptive prevalence in Paraguay: major findings and results from a 1977 survey: analytical report (revised May 1978)
  341. Contraceptive Prevalence survey: model for supervisors manual. [Encuesta de prevalencia del uso de anticonceptivos.]
  342. Contraceptive prevalence survey: model questionnaire.
  343. Contraceptive reliability of cervical contraceptive devices (Letter) [Empfaengnisverhuetung: Wann sind Barriere-Methoden empfehlenswert?]
  344. Contraceptive research (Statement, March 9, 1978)
  345. Contraceptive research funding: eroded by inflation, increasingly dependent upon government support.
  346. Contraceptive research projects were awarded $1.5 mil. by Ford Foundation.
  347. Contraceptive services for adolescents. (Statement, March 1, 1978)
  348. Contraceptive services of the family planning programs of the Western Hemisphere.
  349. Contraceptive services of the family planning programs of the Western Hemisphere. [Servicios anticonceptivos de los programas de planificacion fam.]
  350. Compulsion in family planning: some fundamental considerations.
  351. Computerized patient flow analysis of family planning clinics.
  352. Concepts of family planning.
  353. Concern about family planning.
  354. The Concerned Women for Family Planning of Bangladesh: description and implications for family planning. (Statement, April 27, 1978)
  355. (Concerns of providers of family planning services.) (February 22, 1978)
  356. Concluding remarks (on contraception)

     

  357. Condylomata, hormonal contraceptives and candidiasis: and their interrelationships in women attending a clinic for venereal diseases. [Kondylomer, hormonale kontraceptiva og candidiasis: og disses indbyrdes relation hos en venereakliniks kvindelige patienter.]
  358. Considerations in the management of patients taking oral contraceptives.
  359. Constraints on use and impact of contraceptives in rural Bangladesh: some preliminary speculations.
  360. Contact lens tolerance and oral contraceptives.
  361. Contact lens tolerance and the use of oral contraceptives.
  362. Continued use of contraception among Philippine family planning acceptors: a multivariate analysis.
  363. Contraception above forty. [La contraception apres 40 ans.]
  364. Contraception according to Judaism. [La contraception selon le Judaism.]
  365. Contraception after age of 40. [La contraception apres 40 ans.]
  366. Contraception after pregnancy.
  367. Contraception and abortion services at Barros Luco Hospital, Santiago, Chile.
  368. Contraception and antenatal care. [Contraception et surveillance de la grossesse.]
  369. Contraception and fertility: analysis of 1090 pregnancies. [Anticonception y fucundidad: analisis de 1090 embarazos.]
  370. Contraception and health care among young Canadian women.
  371. Contraception and pregnancy in the young female hypertensive patient.
  372. Contraception and sex education (Statement, March 1, 1978)
  373. Contraception and sterilisation. (Editorial)
  374. Contraception at Port Elizabeth Clinics.
  375. Contraception before pregnancy: evolution between 1972 and 1975 in the Rhone-Alpes region. [La contraception avant une grossesse: evolution entre 1972 et 1975 dans la region Rhone-Alpes.]
  376. Contraception during puerperium. [La contraccezione in purperio.]
  377. Contraception for 40-year-old women. [La contraception chez la femme de 40 ans.]
  378. Contraception for adolescents.
  379. Contraception for the unmarried.
  380. Contraception in adolescence: a review of the literature.
  381. Contraception in adolescents. [Kontrazeptionsberatung bei jungen Maedchen.]
  382. Contraception in adolescents. [La contraception chez l'adolescente.]
  383. Contraception in children and adolescents. [Empfaengnisverhuetung bei Kindern und Jugendlichen.]
  384. Contraception in diabetic women. [La contraception chez la femme diabetique.]
  385. Correlations of contraceptive behavior among unmarried North American university students. [Correlaciones del comportamiento anticonceptivo entre universitarios Norteamericanos solteros.]
  386. The correspondence of data gathered from husband and wife: implications for family planning studies.
  387. Cost-effectiveness analysis and optimal resource allocation: the Philippine Family Planning Program.
  388. Costa Rica's first lady supports family planning.
  389. Costa Rica: contraceptive prevalence survey: summary report.
  390. Counseling regarding birth control methods.
  391. The country paper and progress report on the integrated project of family planning and parasite control, Malaysia.
  392. A country profile and some brief background information on the national family planning programme 1974-1979. 2nd ed.
  393. Country report on the Singapore Family Planning and Population Programme.
  394. A critical analysis of Doctors' attitudes towards a possible extra-medical distribution of oral contraceptives. [Analyse critique de l'attitude des medecins face a la possibilite d'etablir une distribution extra-medicale du contraceptif oral.]
  395. A critical assessment of measures for evaluating population and family planning programs.
  396. A cross-cultural study of menstrual cycle characteristics of women practicing sympto-thermal method of natural family planning.
  397. Cuba: fertility, differentials, contraception and abortion in selected areas. [Cuba: fecunidad, diferenciales, contracepcion y abortos en zonas seleccionadas.]
  398. Cultural factors affecting the acceptability of community-based contraceptive distribution: a Mexican demonstration project.
  399. Current efforts to develop male hormonal contraception.
  400. Current use of contraception.
  401. (Current use, failures in use, and public access to accurate information on contraceptive methods.) (Statement, February 21, 1978.)
  402. Current users of family planning by method, region and province as of June 30, 1978.
  403. Cyproterone acetate (CPA) a potential male contraceptive: further studies on the interactions with endocrine parameters.
  404. Cytogenetic studies of women during and after use of hormonal contraceptives. [Zytogenetische Untersuchungen von Frauen wahrend und nach der Einnahme hormonaler Kontrazeptiva.]
  405. Cytologic detection and clinical significance of Actinomyces israelii in women using intrauterine contraceptive devices.
  406. The Danfa Family Planning Program.
  407. Decision-making in family planning among selected acceptors in the University Health Service Family Planning Clinic.
  408. Decline in breastfeeding endangers infant health, leads to more births unless contraception used.
  409. Definitive contraception and contraceptive responsibility: On the psychic situation in voluntary sterilization in men and women: Results of psychologic-psychiatric research (author's transl) [Definitive Kontrazeption und kontrazeptive Verantwortung: Zur psychischen Situation bei der freiwilligen Sterilisation des Mannes und der Frau: Ergebnisse psychiatrisch-psychologischer Forschung.]
  410. Delayed adverse effects of contraceptives. [Az antikoncipiensek kesoi iatrogeniajarol.]
  411. Demand for family-planning services.
  412. Demand for natural contraception is increasing.
  413. The demographic assessment of family planning programs: a bibliographic essay.
  414. Demographic characteristics and contraceptive practices of abortion patients at a New Zealand medical centre.
  415. Demographic-social and family planning aspects of contraceptive sterilization in countries other than the United States, Puerto Rico, and India.
  416. (The Department of Health, Education, and Welfare's activities in the areas of natural family planning and infertility services and research.) (Statement, June 16, 1978)
  417. 'Natural' methods of family planning.
  418. 15 years' work in population and family planning. [15 anos de labor en poblacion y planificacion familiar.]
  419. 1976 National Acceptor Survey (NAS): estimation of national contraceptive prevalence from survey data on acceptors.
  420. 1978 report of the integrated program for family planning promotion and parasite control in Taiwan, Republic of China.
  421. Abortifacient effect of intrauterine contraceptive devices?
  422. Abortion, birth control and sex ratio in England and Wales. (Letter)
  423. Abortion, contraception, and maternity protection - Italy.
  424. Abortion: some observations on the contraceptive practice of women referred for psychiatric assessment in Dunedin.
  425. Absence of capillary microangiopathy in oral contraceptive users with glucose intolerance.
  426. Absorption of stable isotopes of iron, copper, and zinc during oral contraceptive use.
  427. Acceptability and use-effectiveness of contraception for teenagers.
  428. Acceptability of contraceptive sterilization: psychosocial research approaches.
  429. (The accomplishments and plans of federally subsidized family planning programs.) (Statement, February 22, 1978.))
  430. Acquired colour losses and oral contraceptives.
  431. Acromegaly and articular lesions caused by contraceptives. [Contraceptivumok okozta acromegalia es mozgasszervi manifestaciok.]
  432. Actinomycosis infections associated with intrauterine contraceptive devices and a vaginal pessary.
  433. Actinomycosis of the urinary bladder: association with an intrauterine contraceptive device.
  434. Activities of the family planning center at the Institute of Gynecology and Obstetrics of the University of Rome during the 2 years of 1975-76. [L'attivita del centro di pianificazione familiare dell'istituto de Clinica Ostetrica e Ginecologica dell'Universita de Roma nel biennio 1975-76.]
  435. Acute intermittent porphyria on withdrawal of oral contraceptives.
  436. The administration of national family planning programmes.
  437. Adolescent contraception.
  438. Adolescent contraception. [La contraccezione nell'adolescente.]
  439. Adolescent family planning services in a comprehensive multi-service center: characteristics of users and patterns and correlates of use.
  440. Adolescent health services and contraceptive use.
  441. Adolescent males: attitudes towards abortion, contraception, and sexuality.
  442. Adolescent sexual activity: Contraception and abortion.
  443. Adolescents-the improbable contraceptors: contraceptive behavior and the adolescent. (The Ford Report on Adolescent Sexuality)
  444. Adolescents-the improbable contraceptors; contraceptive risk-taking. (The Ford report on adolescent sexuality.)
  445. Advantages and risks of different contraceptives. [Vinster och risker med olika preventivmedel.]
  446. Adventures and misadventures with contraception] (Statement, March 7, 1978.
  447. Adverse effects of oral contraceptives: July 1974 through December 1977. (659 citations))
  448. Advertising of contraception.
  449. Africa: family planning acceptable for spacing, not to end childbearing.
  450. Africa: support for family planning grows.
  451. Age-specific mortality trends in the United States relative to use of oral contraceptives.
  452. Agreement rates between oral contraceptive users and prescribers in relation to drug use histories.
  453. AID investment of $1 billion in family planning/population is resulting in sharp birthrate declines.
  454. (The Alan Guttmacher Institute's research into family planning needs and unmet needs.) (Statement, February 22, 1978)
  455. Algorithms for a stochastic model of human fertility under contraception.
  456. An alternative delivery system to maximize family planning acceptance by utilizing community leaders in urban low income area.
  457. Ambulatory maternal health care and family planning services: policies, principles, practices.
  458. The AMCH Family Planning Project of the Institute of Maternal and Child Health: the tenth year 1967-1977.
  459. Amenorrhea after oral contraceptives.
  460. Amenorrhea after stopping oral contraceptives: national investigation. [Amenorrhees constatees apres arret des contraceptifs oraux. A propos d'une enquete nationale.]
  461. An analysis of currently practicing rate of contraception based on the 1976 national fertility and family planning evaluation survey (Abstract)
  462. Analysis of family size and decomposition of contraceptive prevalence rates in Boaco, Nicaragua.
  463. An analysis of the use of Copper-7 intra-uterine contraceptive device: a study from Birmingham.
  464. An annotated bibliography of selected materials concerning men and family planning.
  465. Anti-androgen oral contraceptives.
  466. Anti-prostaglandin therapy in prevention of side-effects of intrauterine contraceptive devices.
  467. Antiepileptic drugs and oral contraceptives: preliminary note. [Farmaci antiepilettici e contraccezione orale: nota preliminare.]
  468. Antithrombin III levels in Indian women during pregnancy, post-partum and intake of oral contraceptives.
  469. Approval of Depo-Provera for contraception denied.
  470. Argentina: demography, family planning and human rights. [Argentina: demografia, planification familiar y derechos humanos.]
  471. Assessment of ovarian function in perimenopausal women after stopping oral contraceptives.
  472. An assessment of population and family planning in Peru.
  473. Assessment of the Bangladesh Contraceptive Social Marketing Project: methodology and basic data.
  474. Assessment of the Matlab contraceptive distribution project: implications for program strategy.
  475. The association between cancer of the breast and endometrium and the use of oral contraceptives.
  476. The association between oral contraception and hepatocellular adenoma: preliminary report.
  477. Association of oral contraceptives and cervical dysplasia: CSS file.
  478. Asymptomatic liver cell adenomas: another case of resolution after discontinuation or oral contraceptive use.
  479. Attitude of the school going adolescents towards parental birth control.
  480. Attitude related to reproductive and contraceptive behavior among mothers delivered at Dacca Medical College Hospital, Dacca, Bangladesh.
  481. Attitudes concerning family size, sex preference, and the practice of family planning contraception.
  482. Attitudes towards family size and family planning in rural Ghana-Danfa Project: 1972 survey findings.
  483. An attitudinal and motivational study of early and late adoptors of family planning among women.
  484. Availability of family planning services.
  485. Available contraception lowers teen birthrates.
  486. Awareness of unmarried girls regarding population problem, human reproduction and family planning.
  487. Background and development of the National Reporting System for Family Planning Services.
  488. Background information and need for injectable contraceptives in the United States. (Statement, August 8, 1978)
  489. The balances of contraceptive methods. [Editorial]
  490. Barrier contraceptive practice and male infertility as related factors to breast cancer in married women.
  491. Barrier contraceptive practice and male infertility as related factors to breast cancer in married women: preliminary results.
  492. Barrier methods of contraception: problems and prospects for the developing world.
  493. Barriers against the acceptance of family planning in rural Bangladesh.
  494. Barriers to the diffusion of contraceptive sterilization.
  495. Basic facts about contraception.
  496. Basic guidelines for propagating family planning in business organizations.
  497. Basic information on family formation and family planning in rural Bangladesh.
  498. Behavior of the male population with respect to family planning in Trujillo, Peru. [Comportamiento de la poblacion masculina con respecto a la planificacion de la familia en Trujillo, Peru.]
  499. Beliefs regarding the consequences of birth control among black, colored, Indian, and white South Africans.
  500. Beneficial effects of contraceptive doses and large doses of medroxyprogesterone in the prevention and treatment of uterine hyperplasia. [Effets benefiques de la medroxyprogesterone a dose contraceptive et a forte dose dans la prevention et le traitement des affections hyperplasiques de l'uterus.]

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.